LBL ...well before we get too carried away on PPS ...remember AMRN is not vertically integrated . So lets hope we don't get an anchovy fisherman's cartel ...:-) Kiwi
Just for the record B.B. is a Frenchfry short of a Happy Meal. As much as I would like to see valuation of $400 it may take some time. I think for the long term $150-200 might be a reasonable expectation.
Yes...I have for many years considered Amarin to be more like a beverage company...(Think Coke or Pepsi) than a biotech or a BP...Revenues are generated by sales of bottles (actually capsules in this case)...only Amarin would have much more captive customers...On it for a day...on it for life...Imagine 25 million customers and Amarin making .25$/capsule.profit....That would be $25 Mil profit per day...
I agree with you about the spread of V usage....Should occur faster than most think...5 G is about to be released....Vascepa will benefit from 5 G speed and its effect on medical information...
The future looks bright....Vascepa is the future...
News 
Market Data 
Discover 
